These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16152588)

  • 1. Effect of an anti-CD54 (ICAM-1) monoclonal antibody (UV3) on the growth of human uveal melanoma cells transplanted heterotopically and orthotopically in SCID mice.
    Wang S; Coleman EJ; Pop LM; Brooks KJ; Vitetta ES; Niederkorn JY
    Int J Cancer; 2006 Feb; 118(4):932-41. PubMed ID: 16152588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Fc portion of UV3, an anti-CD54 monoclonal antibody, is critical for its antitumor activity in SCID mice with human multiple myeloma or lymphoma cell lines.
    Coleman EJ; Brooks KJ; Smallshaw JE; Vitetta ES
    J Immunother; 2006; 29(5):489-98. PubMed ID: 16971805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antitumor activity of an anti-CD54 antibody in SCID mice xenografted with human breast, prostate, non-small cell lung, and pancreatic tumor cell lines.
    Brooks KJ; Coleman EJ; Vitetta ES
    Int J Cancer; 2008 Nov; 123(10):2438-45. PubMed ID: 18752248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD54 (ICAM-1) has antitumor activity in SCID mice with human myeloma cells.
    Huang YW; Richardson JA; Vitetta ES
    Cancer Res; 1995 Feb; 55(3):610-6. PubMed ID: 7834632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anti-ganglioside antibodies on the metastatic spread of intraocular melanomas in a nude mouse model of human uveal melanoma.
    Niederkorn JY; Mellon J; Pidherney M; Mayhew E; Anand R
    Curr Eye Res; 1993 Apr; 12(4):347-58. PubMed ID: 8319494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas.
    Ma D; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1067-75. PubMed ID: 9620065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The generation and anti-myeloma activity of a chimeric anti-CD54 antibody, cUV3.
    Smallshaw JE; Coleman E; Spiridon C; Vitetta ES
    J Immunother; 2004; 27(6):419-24. PubMed ID: 15534485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
    Némati F; Sastre-Garau X; Laurent C; Couturier J; Mariani P; Desjardins L; Piperno-Neumann S; Lantz O; Asselain B; Plancher C; Robert D; Péguillet I; Donnadieu MH; Dahmani A; Bessard MA; Gentien D; Reyes C; Saule S; Barillot E; Roman-Roman S; Decaudin D
    Clin Cancer Res; 2010 Apr; 16(8):2352-62. PubMed ID: 20371695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
    Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
    Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2337-42. PubMed ID: 18515579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between natural killer cell susceptibility and metastasis of human uveal melanoma cells in a murine model.
    Ma D; Luyten GP; Luider TM; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):435-41. PubMed ID: 7843912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of chemokine receptors on uveal melanoma cells and their metastases.
    Li H; Alizadeh H; Niederkorn JY
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):636-43. PubMed ID: 18235009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral picropodophyllin (PPP) is well tolerated in vivo and inhibits IGF-1R expression and growth of uveal melanoma.
    Economou MA; Andersson S; Vasilcanu D; All-Ericsson C; Menu E; Girnita A; Girnita L; Axelson M; Seregard S; Larsson O
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():35-41. PubMed ID: 19032680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary report on monoclonal antibodies against human uveal melanoma.
    Kalafut F; Kusenda J; Novotná L; Cernák A
    Neoplasma; 1987; 34(6):693-701. PubMed ID: 3431609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The insulin-like growth factor-I receptor inhibitor picropodophyllin causes tumor regression and attenuates mechanisms involved in invasion of uveal melanoma cells.
    Girnita A; All-Ericsson C; Economou MA; Aström K; Axelson M; Seregard S; Larsson O; Girnita L
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():26-34. PubMed ID: 19032679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro targeting of NG2 antigen by 213Bi-9.2.27 alpha-immunoconjugate induces cytotoxicity in human uveal melanoma cells.
    Li Y; Wang J; Rizvi SM; Jager MJ; Conway RM; Billson FA; Allen BJ; Madigan MC
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4365-71. PubMed ID: 16303921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody.
    Guo Y; Ma J; Wang J; Che X; Narula J; Bigby M; Wu M; Sy MS
    Cancer Res; 1994 Mar; 54(6):1561-5. PubMed ID: 7511044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An orthotopic model for human uveal melanoma in SCID mice.
    Mueller AJ; Maniotis AJ; Freeman WR; Bartsch DU; Schaller UC; Bergeron-Lynn G; Cheng L; Taskintuna I; Chen X; Kan-Mitchell J; Folberg R
    Microvasc Res; 2002 Sep; 64(2):207-13. PubMed ID: 12204644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody.
    Hafner C; Breiteneder H; Ferrone S; Thallinger C; Wagner S; Schmidt WM; Jasinska J; Kundi M; Wolff K; Zielinski CC; Scheiner O; Wiedermann U; Pehamberger H
    Int J Cancer; 2005 Apr; 114(3):426-32. PubMed ID: 15578703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
    Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells.
    Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S
    Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.